2\COX2\CerbB2在乳腺癌中表达的研究> PS2\COX2\CerbB2在乳腺癌中表(3)
| 第1页 |
参见附件。
[2] Lanza-Jacoby S,Burd R,Rosato FE Jr,et al Effect of simultaneous inhibition of epidermal growth factor receptor and cyclooxygenase-2 in HER-2/neu-positive breast cancer Clin Cancer Res,2006,15(12):6161-6169.
[3] Grudzinski M,Cambruzzi E,Lahude E,et al COX-2and CD105 expression in breast cancer and disease-free survival Rev Assoc Med B ras,2006,52(4):275-280.
[4] Liu C H,Chang S H,Narko K,et al.Overexpressinon of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice.J Biol Chem,2001,276:18563-18569.
[5] Ristimaki A,Sivula A,Lundin J,et al.Prognostic ssignificance of elevated cyclooxygenase-2 expression in breast cancer.Cancer Res,2002,62(3):632-635.
[6] 罗仁峰乳腺癌组织PS2与雌激素和孕激素受体的关系及预后意义.亚太传统医药,2008,7(4):11-12.
[7] Schwatz L H,Koemer FC,Edgerton SM,et al.PS2 expression and response to hormonal therapy in patients with advanced breast cancer.Cancer Res,1991,51(2)624.
[8] Thompson AM,Elton RA,Hawkins RA,et al.PS2 mRNAexpression adds prognostic information to node status for 6-year survival in breast cancer.Br J Cancer,1998,77(3):492.
[9] 杨丽芳,宋三泰,等.雌激素诱导蛋白PS2表达与ER阳性原发乳腺癌患者辅助内分泌治疗疗效的关系中国研究与临床,2004,16(2):97-99.
[10] 龚益平,吴昌鸣,杨晓玲.乳腺癌PS2蛋白表达与临床病理联系的研究.肿瘤防治研究,2005,32(1):13-14.
[11] 储兵,侯襄河,黄光辉,等.ER、PR、CerbB2在不同年龄组乳腺浸润性导管癌中的表达.医学论坛杂志,2008,29(14):65-68.
您现在查看是摘要介绍页，详见PDF附件。